Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
UNVC MJ 1) going major Pharma via Merck. Not an opinion!
2) Ours has an international distribution network in play
3) We have 70,000 pharmacies to distribute through via Health Resources Inc
4) We have more products than just a patch and many will be PRESCRIPTION unlike the seedy strip mall dispensaries
$INTK filings are out and yield sign is gone. PINK CURRENT FINALLY!
OriginClear, Inc. $OCLN Showing Off the AOxPlus Prototype
https://www.originclear.com/video/showing-off-the-aoxplus-prototype
Medical Marijuana $CIIX Expands CBD Sales In China
http://wallstreetnewscast.com/ciix-0822/
$CLDC China Lending provides collateralized credit-based financings to northwest China's fast-growing micro, small and medium sized enterprises (“MSMEs”), customers currently underserved by commercial banks due to fundamental flaws in China’s credit system.
MAXD just listed as a partner on Qualcomm site!!
VIDEO LINK $TREP
CFGX Pink Current - trading at 0005 with NO convertible debt. OS 2bil.
MCGI: EXCELLENT POTENTIAL HERE
Merger in the works with LiftKits4Less.
4Less operates in the $43 billion specialty aftermarket auto parts industry and has quickly grown into one of the largest on-line sellers of Jeep, Truck and SUV suspension systems and related accessories targeting direct to consumer and installation shops here in the US and ships worldwide.
We are sitting on something under the radar and very special here!!!
MERGER PR:
https://www.otcmarkets.com/stock/MCGI/news/story?e&id=1108726
LIFTKITS4LESS website and facebook:
https://liftkits4less.com/
https://www.facebook.com/liftkits4less
Nice overview by mvp_stocks:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=142290877
4Less established www.LiftKits4Less.com approximately 3 years ago. In 2015, their first year of operations, Liftkits had revenues of $2.4M which they grew by 280% to $6.8M in 2017 and was close to break even. For 2018 they are on track to surpass revenues of 9 million dollars.
They utilize technology and the internet to conduct their business. They are like the orbitz of lift and suspension for Trucks and SUV's. They've no distribution or shipping costs. No extra overhead of inventory and distribution. Minimal need for staff or bigger space, etc. They can go to $50M in annual profit utilizing economies to scale with minimal spending necessary to get there!!! The main cost was getting the platform established and in place. That is already the case with lifts4less and all the connections with manufacturers are in place as well. REAL COMPANY GENERATING AND GROWING REAL REVENUES TODAY!!!
CEO EMAIL: mvp_stocks
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=142900517
INFORMATION ABOUT OUR CEO AND SS (VERY IMPRESSIVE): stervc very informative posts!!!
MCGI CEO is Founder of Monster.com Subsidiary...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=140486845
MCGI CEO Previous $62 Million CBS Deal...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=140487140
Huge MCGI OS Confirmation in 10-Q...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=140517796
900 million O/S is nothingness. How many of those shares are in the float (700 million?) and how many are locked up by investors wanting in on this huge event. We have already seen posts where employees and folks close to the company are buying in. The transaction of the upcoming event has been PR'd so folks close to the situation are taking the opportunity to buy in prior to its finalization. Q4 2018 and 2019 are going to be huge for MCGI.
GOING FORWARD THERE IS AMPLE ROOM FOR REVENUE GROWTH IN THIS 43 BILLION AND GROWING TARGET MARKET
well beyond the 9+ million already being generated thus far this year!
With their proven business model, experienced management team, and relationships with thousands of manufacturers, 4Less is in the early stages of launching other related auto equipment ecommerce websites including Bumpers4Less.com, Shocks4Less.com and Truckbedcovers.com to name a few.
No guarantees in the world of OTC but I sure like our chances sitting here at .001 and soon to R/M in 9 million and growing revenues REALIZED TODAY with a CEO who knows how to make the most out of a popular and growing internet B to C business!!! He has done it before with jobs.com/Monster.com!!!!
$MCGI
$CIIX Powering up, coming. Patience!!!! CIIX
$CIIX NO BRAINER!
$CIIX SMART MONEY ACCUMULATING DOWN HERE!
$FRLF -->1 dolla holla. get on board.
INTK, Filings posted om OTC. Current any day. Updates to follow.
$NOUV 165 Million on .0003 L2 Showing .0005
RJDG RUNNING ON ACQUISITION NEWS - GET IN -LOW FLOATER
Papa is everything ok on your end. Just making sure your ok from the storm
$BLPG .0079
https://www.bluelineprotectiongroup.com/
Profitable cannabis asset protection company with 177 million O/S. Net profits of over .01 per share quarter 1 this year at $2 million
Audited financials
Largest provider of cannabis security in Colorado with offices now in Nevada and Arizona
Expansion plans for Washington, Oregon, and California
85 full and part time employees
Featured in news articles and video documentaries by outlets such as the Wall Street Journal, USA Today, Fortune and CNBC, which have served to increase brand awareness nationwide.
Getting in before the stock takes off is greatest.
$OCSY is a stock just like FRLF.
Ocsy share structure is beautiful at
50 million outstanding shares
7 million float shares
Good press releases every other week about contracts, acquisitions yet still the share price is still below .02.
Noone knows about Ocsy so like your pick, get in before it blasts off.
Ocsy is making Big Deals in cyber security abd acquisitions expanding the business.
Check out a press release and Google Ocsy
Optium announces the 3rd major Cyber Security Consulting and Services Agreement in the last 90 days
March 08, 2018 -
Optium Cyber Systems, Inc. (the Company) (OTC:OCSY) is pleased to announce the signing of a Cyber Security Consulting and Services Agreement worth over $300,000. This is the third major contract the Company has entered into in the last 90 days representing over $800,000 in potential revenue.
This new contract was entered into on March 6, 20178 and will commence March 15, 2018. Under the terms of the agreement, Optium Cyber Systems will provide the Client with an initial Cyber Vulnerability Assessment (CVA) and then implement an ongoing Managed Security Program to monitor and protect the Client’s IT infrastructure. The Client has agreed to pay Optium Cyber Systems a flat fee of $19,500 for the initial CVA and then $23,400.00 per month thereafter for monitoring and mitigation services. Additional consulting services will be provided on an as needed basis at an additional cost. The contact is for a one-year period.
ABOUT OPTIUM CYBER SYSTEMS, INC.
OCSI has developed a proprietary process to analyze, identify and address cyber security vulnerabilities in an organization’s critical IT infrastructure which is scalable to any size organization in any industry. OCSI has recently launched in the health care sector, focusing on protecting health care facilities including hospitals, nursing homes and doctor’s offices from cyberthreats such as the manipulation of medical devices or theft of patient records. OCSI is a publicly traded company having its common shares quoted on the OTC Markets under the symbol "OCSY
www.optiumcyber.com
Google ocsy
$MCGI: I anticipate some very nice....
returns from the current levels!!!
Bottom is in as I continue to accumulate shares!
I have been selling on upticks in other positions and adding more right here.
MCGI will be a huge winner 2018 on into 2019. Loading is taking place right here. Extremely positive SS and the R/M target already has realized revenues and they continue to grow.
THESE REPRESENT ACTUAL REVENUES BEING GENERATED TODAY!!!
The R/M candidate (4Less) has grown from 2 million to 9 million plus revenues in three years. Expansion of the existing product offering is in place so much more revenues are anticipated over the months/years ahead!
There is no sure thing in the OTC but I sure like our chances especially at these prices.
As filings continue to be released you can bet the PPS will start to reflect the MASSIVE POTENTIAL.
We wait for filings and the R/M to complete. When it completes or nears completion we lift off in a HUGE WAY!!!
REAL COMPANY, REAL TECHNOLOGY, REAL MULTI BILLION DOLLAR TARGET MARKET($43 billion specialty aftermarket auto parts industry), and MOST IMPORTANTLY REAL REVENUES (9 MILLION PLUS and GROWING) BEING GENERATED TODAY!!!
It doesn't get any better in the OTC!!!
If everything goes through and finalizes, hitting .02 to .05 is extremely possible in the early going!!
That would be an incredible holiday return in Q4 of 2018 carrying over into 2019!
$MCGI
$CFGX- NO CONVERTIBLE DEBT- going current, just uploaded 8 filings to OTC- .0003 with 2 bil OS. No dilution on record either.
https://www.otcmarkets.com/stock/CFGX/disclosure
To all OTC CASINO PLAYERS that are in the path of Hurricane Florence ..... please stay safe! I am also currently in NC (near Raleigh) ..... expecting wild weather here tonight!
The CBD Bonanza on the Horizon
Source: NetworkNewsWire
CannabisNewsWire Editorial Coverage: Leveraging ever-expanding scientific evidence of the therapeutic efficacy of CBD (cannabidiol), specialty biotechnology companies are creating novel new formulations of the chemical compound to capitalize on the titanic growth expected in the cannabis-derived pharmaceutical and nutraceutical markets.
Global medical marijuana market expected to exceed $55 billion by 2025
Global nutraceuticals market projected to surpass $319 billion by 2023
CBD pharmaceutical and nutraceutical companies poised to reap huge rewards
Diverse CBD product lines provide competitive advantages
Cannabinoids have been used for medicinal purposes for millennia, but it wasn’t until the discovery of the human endocannabinoid system in the 1990s that scientists began to comprehend their importance in healing and homeostasis. The identification of human cannabinoid receptors opened the floodgates to new cannabis-based medications. Increased understanding of the endocannabinoid system sparked further scientific research and led to the realization that cannabinoids impact a much wider range of physiological functions than previously realized. Specialty biotechnology companies soon blossomed and now these companies research and develop wide-ranging novel new drug candidates to improve and extend patients’ lives, creating unique medicines to treat multiple maladies and answer unmet medical needs. These pioneering biotech companies are committed to developing cannabis-based pharmaceuticals and nutraceuticals delivered with unparalleled safety and new-found efficacy. At the vanguard of this surge in cannabinoid therapeutics, Earth Science Tech, Inc. (OTC: ETST) (ETST Profile) has taken another major step in its mission to become a global leader in the research, development and sale of hemp-derived, CBD-based pharmaceuticals, nutraceuticals and dietary supplements. The company’s recent decision to uplist on the OTCQB exchange will likely increase visibility and liquidity, and its comprehensive strategy of scientific development combined with robust retail creates a unique opportunity in the burgeoning medical cannabis markets. Other companies vying for position in these lucrative markets include CV Sciences, Inc. (OTC: CVSI), Axim Biotechnologies, Inc. (OTC: AXIM), GB Sciences, Inc. (OTC: GBLX) and Vitality Biopharma (OTC: VBIO).
To view an infographic of this editorial, click here.
Massive Markets
Little wonder that cannabis biotech companies are operating at full throttle. The global medical marijuana market is anticipated to exceed $55 billion by 2025 and, to meet increasing consumer demand, hemp-based nutraceuticals are rapidly gaining significant traction in a global nutraceuticals market projected to surpass $319 billion within the next five years. These eye-popping projections bode well for diversified cannabis biotech companies. CBD pharmaceuticals and nutraceuticals are the fastest growing sectors in the legal cannabis markets and the sector itself is among the fastest growing in all the markets. With multiple clinical research studies suggesting that CBD based pharmaceuticals and nutraceuticals have the potential to treat arthritis, MS, chronic pain, depression, epilepsy and a myriad of other illnesses and maladies, the prodigious market projections might even be underestimated.
Another Milestone
Seizing on the immense market opportunity and validating efficacy through scientific processes, Earth Science Tech, Inc. (OTC: ETST) is intent on becoming a global leader in the research, development and sale of hemp-derived, CBD-based pharmaceuticals, nutraceuticals and dietary supplements. The company has racked up a succession of achievements since inception and its latest announcement establishes another milestone in its march toward global recognition. The company just issued a press release confirming that the U.S. Securities and Exchange Commission (SEC) approved the company’s Form 10 Registration Statement and Earth Sciences has officially up-listed to an OTCQB fully reporting company as of Sept. 10. The higher standards of the OTCQB markets provide a strong baseline for transparency, as well as the technology and regulations to enhance both access to information and trading experiences for investors. “Historically, up-listing to the OTCQB and being fully reporting has resulted in greater liquidity and awareness. We are committed to the higher level of corporate and financial disclosures required as an OTCQB fully reporting company, demonstrating our commitment to our loyal shareholders,” stated ETST’s President, Director and Chairman Nickolas S. Tabraue.
Eyes on the Prize
Grounded in science, ETST still understands that sales are essential for continued success. Earth Science aggressively markets and sells the highest-available quality and purity full spectrum hemp oil containing CBD. The company’s products are formulated using superior supercritical CO2 cold liquid extraction, where the cannabinoids are kept at the rawest state possible to maintain essential therapeutic properties. Earth Science’s CBD products are marketed through multiple venues including a national group of independent distributors representing grocery and convenience stores, a national association of buying groups and trade organizations reaching up to 90,000 retail outlets, health food giant Karmavore Superfoods, international supplement distributor Forzagen, innumerable vape and e-liquid smoke shops, and online.
The company has four distinct, wholly owned subsidiaries:
Cannabis Therapeutics, Inc., (CTI) is developing an array of cannabinoid-based pharmaceuticals and nutraceuticals.
Kannabidioid, Inc., manufactures and distributes vapes/e-liquids and gummy edibles to vape and smoke shops.
Earth Science Pharmaceutical, Inc., (ESP) manufactures low-cost medical devices and vaccines for protection against sexually-transmitted infections.
Earth Science Foundation, Inc., a nonprofit organization formed to accept grants and donations to conduct further studies and help donate CBD products to those in need.
Cannabis Therapeutics is deeply invested in research and development to explore and harness the medicinal power of cannabidiol. Over 113 cannabinoids have been isolated from the cannabis plant, many obscure and only in trace amounts, but CBD, for which Cannabis Therapeutics has a provisional application patent, is the most promising of all. CTI’s mission is to develop proprietary cannabinoid-based nutraceuticals and pharmaceutical products using Earth Science Tech’s existing cannabis CBD patent and IP, as well as expected future technologies.
The company recently updated its report on research progress on two new cannabinoid-based pharmaceutical drugs, which are unique CBD formulated products – a neuron protector and a breast protector. Earlier studies by DV Biologics, a leading biological company, confirmed ETST high-grade hemp CBD oil deterred the formation of reactive oxygen species and cell death in human brain cells in vitro and may serve as a neuroprotectant to mitigate neurodegenerative disorders such as Alzheimer's and Parkinson's. With strong initial evidence that CBD contains anti-breast cancer properties, Earth Sciences also launched the development of proprietary prophylactic therapies to prevent breast cancer, and a treatment to help women with aggressive breast cancer. The company is very bullish on these CBD formulas.
The R&D work in progress at the prestigious laboratory, Centre De Développement Bioalimentaire Du Québec (CDBQ), has been exceptionally promising. CDBQ is highly experienced and able to utilize the most effective and economical solutions to develop products with the best efficacy and price-to-quality-to-market ratios. CDBQ is meticulously finalizing formulations that will include natural protective agents to assure long shelf life of the CBD formula.
The third CBD formula is a revolutionary superfood with unique organoleptic properties never seen on the market. Formulated from a mix of hemp oil and other vegetal oils, and enriched with a highly potent antioxidant, this product is designed to improve antioxidant ingestion. Earth Science developed this novel formula in collaboration with experts that successfully developed multiple products for some of the largest players in the food industry.
Not a One-trick Pony
Earth Science’s up-listing announcement is only the latest in a succession of successful advancements the company has made since its genesis. Last year’s achievements verify that. In addition to talented and experienced leadership, the company’s success lies in the broad diversification of products, joint ventures, IPs and initiatives. Beyond the company’s multiple CBD-based initiatives and ventures, Earth Science’s medical device subsidiary Earth Science Pharmaceutical is making significant strides in the development of low-cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. ESP is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
Others Vying for Position
CV Sciences, Inc. (OTC: CVSI) focuses on the drug development, marketing and sale of products containing cannabidiol as the active pharmaceutical ingredient, and is engaged in the sale of CBD as well. The company operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and a consumer product division centered in the manufacturing, marketing and sale of plant-based CBD products to a range of market sectors.
Axim Biotechnologies, Inc. (OTC: AXIM) researches, develops and produces cannabis-based pharmaceutical, nutraceutical and cosmetic products. The company has several products developed or in developmental stage for the treatment and/or prevention of multiple conditions and symptoms. Axim’s flagship products include a CBD-based, controlled-release chewing gum, another gum containing 50 mg of CBD undergoing clinical trials in patients with irritable bowel syndrome, and a combination CBD/tetrahydrocannabinol (THC) gum that will undergo clinical trials for the treatment of pain and spasticity associated with MS.
GB Sciences, Inc. (OTC: GBLX) is a diverse cannabis company focused on standardized cultivation and production methods, as well as biopharmaceutical research and development. The company’s goal is to create safe, standardized, pharmaceutical-grade cannabinoid therapies that target a variety of medical conditions. Company growth strategy is two-pronged — biomedical research for the development of cannabis-based therapies and the recreational market for cannabis in Nevada.
Vitality Biopharma (OTC: VBIO) is focused on the use of cannabinoids for the treatment of serious neurological and inflammatory disorders. The company has developed cannabinoid prodrugs, known as cannabosides, which upon ingestion may enable selective delivery of THC and CBD to the gastrointestinal tract. Vitality has filed intellectual property applications and is seeking global patent protection for prodrugs of THC, CB, and CBDV, as well as for its proprietary prodrug biosynthesis platform utilizing enzymatic glycosylation.
The Takeaway
As the list of curative applications continues to grow, there’s no longer any doubt about the therapeutic efficacy of cannabidiol. Employing that same certitude for impending CBD market growth has the potential to create a profit bonanza in strategically positioned portfolios.
For more information on Earth Science Tech, visit Earth Science Tech, Inc. (OTC: ETST)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000
For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.
Source:
CannabisNewsWire
Contact:
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net
New Technologies May Turn Arkansas into a Lithium Superpower
Source: NetworkNewsWire
NetworkNewsWire Editorial Coverage: Consumers are switching to electric vehicles faster than previously thought, making an expected boom in demand for battery-grade lithium ever more real. Current suppliers including Albemarle Corp. (NYSE: ALB) and Sociedad Quimica y Minera de Chile (NYSE: SQM) will reap the rewards of a major paradigm shift in the car industry. But newcomers to this market, from Nemaska Lithium (TSX: NMX) (OTC: NMKEF) and Standard Lithium (TSXV: SLL) (OTC: STLHF) (STLHF Profile) may also profit as they bring new supplies online. Major buyers of lithium including automaker Tesla Inc. (NASDAQ: TSLA) could create massive new demand for this material.
Electric vehicle (EV) sales will surge to 1.6 million units worldwide this year, from a few hundred thousand in 2014, according to Bloomberg New Energy Finance. The growing popularity of EVs has had an effect across the entire automotive industry: German automaker Audi (NSU.DE) unveiled a new electric supercar at the Pebble Beach Automotive Week this summer, and new manufacturers are expected to enter the market as well.
Home vacuum manufacturer Dyson has revealed intentions to create an electric vehicle, investing £200 million in a test facility in Hullavington, Wiltshire, England. The test facility will be where Dyson develops its first electric vehicle, which the company has invested £2 billion towards so far. Dyson has partnered with lithium-ion battery producer Sakti3, a firm that claims to have developed a solid-state lithium-ion battery that produces over 400 Wh/kg energy density. Tesla’s Panasonic batteries are considered the industry leader at only 240Wh/kg.
If consumers transition to EVs faster than expected, the scene could be set for a lithium supply crunch as manufacturers seek the raw materials needed in lithium-ion batteries used by the automotive industry. A Tesla Model S battery pack utilizes 63 kilograms of lithium, an amount that eclipses the amount of lithium currently used in mobile phones and iPads. That requires building a new supply chain several times larger than the existing one.
Companies that might do well in this paradigm shift are those that are working on new technologies to rapidly increase the global supply of lithium. One such company is Standard Lithium (TSXV: SLL) (OTC: STLHF). Standard Lithium is working on a processing breakthrough to unlock one of the world’s most exciting untapped lithium resources, which happens to be located in the United States.
To view an infographic of this editorial, click here
Arkansas holds one of the world’s largest lithium opportunities
Arkansas is not renowned for its role in new technologies. The state has a mature oil and gas industry and is one of the world’s largest suppliers of bromine, a chemical used as a flame retardant. The bromine, extracted from wells deep underground, is rich in lithium.
The Smackover Formation in Arkansas could hold 1 million metric tons of lithium reserves or about a third of the reserves of the massive Atacama Salt Lake in Chile. Albemarle and SQM operate two of the world’s three largest lithium extraction sites in the Atacama.
None of the chemical producers operating in Arkansas have figured out how to separate this massive resource from the brine. Albemarle owns a major bromine plant in Arkansas and is conducting its own experiments to find a breakthrough. Lanxess AG (NYSE: TTI) and TETRA Technologies, Inc. (FWB: LXS), two other chemical producers based in the region, recently signed agreements with Standard Lithium to pursue the commercial opportunity of producing lithium battery materials from this strategic resource.
Track Record in Lithium Extraction
Standard Lithium’s management team, led by Chief Executive Officer Robert Mintak, has a track record in lithium extraction. At Canada’s Pure Energy Minerals (OTC: PEMIF), Mintak oversaw the development of a disruptive extraction process, leading to a surge in the company’s share price.
Chief Operating Officer Andy Robinson, who holds a doctorate in geochemistry, has overseen resource development projects around the world. With his team of global experts, Standard Lithium has developed a new rapid lithium extraction process that better extracts the material from a variety of brine sources. The company recently hired Prof. Barry Sharpless, a Nobel Laureate in chemistry, to the company’s Scientific Advisory Council.
Mintak and his team are betting on being able to leapfrog competitors in the lithium supply space by avoiding several of the lengthy and time-consuming phases of developing a greenfield lithium operation. A traditional brine project such as those operated by Albemarle and SQM in Chile requires several phases including resource assessment, permitting, earth-moving and process-testing. Other lithium projects in Argentina have shown lengthy development timelines, which can take up to a decade or more to come online.
By working with permitted chemical producers such as Lanxess and Tetra, which already extract raw material feedstock (brine) from the ground, Standard Lithium can leverage existing infrastructure to eliminate most of the steps toward commercial production. Quick project execution will be key if the EV transformation happens faster than expected.
Only about 2% of global lithium supplies are sourced from North America, according to SQM. Domestic providers may stand to benefit after President Donald Trump initiated a federal strategy to supply critical minerals from within the United States. Lithium is one of a handful of critical minerals that are deemed to be of high importance to the industries of the twenty-first century under the U.S. government strategy.
Tesla is particularly dependent on lithium supplies and has held talks with SQM to sign a long-term supply agreement for a giant lithium-ion battery factory known as the Gigafactory that it is building in Nevada. General Motors is introducing at least 20 EV models by 2023, including the Chevrolet Bolt and Cadillac CT6 Plug-in, CEO Mary Barra said in March.
Drop in Valuations Increases Opportunity
Lithium stocks tumbled this year after investment bank Morgan Stanley said supply from new projects will exceed demand before 2021. That investment advice might not fully reflect the fact that consumers are switching to EVs from internal combustion engines (ICEs) faster than expected, according to London-based analysts Benchmark Mineral Intelligence.
Some major Asian battery makers appear to be taking full advantage of the recent drop in lithium company valuations. POSCO (NYSE: PKX), South Korea’s biggest steelmaker and producer of car batteries, bought the lithium mining rights of Australia’s Galaxy Resources Ltd. (OTC: GALXF) for $280 million in a deal announced Aug. 27. The acquisition appeared to take advantage of a temporary drop in valuations. POSCO, which supplies Korean carmakers such as Kia Motors (OTC: KIMTF), said it would build a lithium plant in Argentina and supply 25,000 tons a year from the Salar del Hombre Muerto project in the South American country. China’s Ganfeng Lithium Co. Ltd. also purchased SQM’s stake in an Argentine lithium project in late August.
Several countries, including China, are mandating shifts from ICE production to EV production, a step that will rapidly accelerate the demand for lithium-ion batteries, according to London-based consultancy Roskill. With government mandates accelerating demand for lithium, supply won’t keep up with need. This could ultimately lead to major lithium buyers looking to back an emerging producer with a large resource such as Standard Lithium.
Other Actors in the Lithium Space
Albemarle (NYSE: ALB) is the world’s largest lithium producer, producing the material from rock mines in Australia and from brine operations in Chile. Albemarle also produces bromine in Arkansas and is experimenting with chemical processes to separate the lithium found in its raw material feedstock. The company is looking to expand its current lithium production capacity to 265,000 tons a year, from 65,000 tons a year at present.
Nemaska Lithium (TSX: NMX) (OTC: NMKEF) is developing a plant to produce car battery-grade lithium hydroxide and recently signed a take-or-pay 5-year supply agreement with Northvolt, a company that is building Europe’s largest battery factory. Nemaska Lithium recently obtained a $75 million payment as part of a multi-stage loan to finance its Whabouchi mine.
Sociedad Quimica y Minera S.A. (NYSE: SQM) based in Santiago, Chile was traditionally the world’s largest lithium producer until it was overtaken by Albemarle in recent years. Sociedad Quimica y Minera S.A. recently secured an agreement with the Chilean government to carry out a major expansion of its lithium brine operation in the Atacama Desert.
Tesla, Inc. (NASDAQ: TSLA) is rapidly expanding output of its Model S and is having a wider disruptive effect on the global automotive market as traditional carmakers switch to electric vehicles from the internal combustion engine. Tesla is building a lithium-ion battery factory in Nevada and is currently seeking a long-term supply agreement with Chile.
Please also read and review and the following article: Will Access to “World Class” Lithium Brine Resource Send This Lithium Miner’s Value Soaring?
For more information on Standard Lithium Ltd., visit Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF)
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, please visit https://www.NetworkNewsWire.com
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by NNW are solely those of NNW. Readers of this Article and content agree that they cannot and will not seek to hold liable NNW for any investment decisions by their readers or subscribers. NNW is a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, NNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
NNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and NNW undertakes no obligation to update such statements.
Source:
NetworkNewsWire
Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Hurricane party today and tomorrow at the CASINO!
BLPG nice day. This is a very unique opportunity here. Only publicly traded company doing what they do in the cannabis sector. This is unheard of in pinkyland.
“We have created a means for the banks to validate compliance with the Federal Mandate. Currently only a security company could match the compliance requirements as only we can vertically integrate the source of funds through the Federally required 12 steps, summarized as from grow, to sale, (to those of approved age or license), to purchaser, to funds received, to where the funds were held, to vault, to third party validation, to tax, to profits, to access to the banking system etc. We are uniquely positioned, through a number of partnership and cooperation agreements, to provide banking solutions to our clients.”
IMUN reloading zone .017-.019
LVCA just went current.
https://www.otcmarkets.com/stock/LVCA/overview
CrazyKar123**WeekyStockPicksMakes it to #1 on the Breakout Boards in Two Weeks
CrazyKar123**WeekyStockPicks**$**10000%
IMUN huge close .0295 -->NICE 126%!!
$IMUN alert! up 45% on buying volume. something coming.
It is a BEAUTIFUL low floater my friend!
PBYA massive Hidden bids!!
Perfect dip buy!!
FRLF chart setting up for big run-->low float and most shares held by insiders
RJDG low floater, emerging upside breakout
UATG!! nice lil low floater!!! nice news!!!
Emerging Sewer-Fed Trade Ideas: RJDG GMGI MSPC RBII
News coming any time - should be a runner this month. $RBII - War
Followers
|
98
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3369
|
Created
|
05/25/18
|
Type
|
Free
|
Moderators CHIEF-RISES-ABOVE Rory2 |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |